Sangamo Therapeutics
SGMO
SGMO
217 hedge funds and large institutions have $1.1B invested in Sangamo Therapeutics in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 57 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more call options, than puts
Call options by funds: $36.1M | Put options by funds: $36M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.09% less ownership
Funds ownership: 63.79% → 63.7% (-0.09%)
Holders
217
Holding in Top 10
2
Calls
$36.1M
Puts
$36M
Top Buyers
| 1 | +$17.2M | |
| 2 | +$10.2M | |
| 3 | +$10.2M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$8.24M |
| 5 |
Millennium Management
New York
|
+$7.59M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$19.8M | |
| 3 | -$15.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.2M |